Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New surgical tweak may cut acid reflux after gastric sleeve

NCT ID NCT07560787

Disease control Sponsor: Van Training and Research Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether adding a crural repair and gastropexy to standard sleeve gastrectomy reduces acid reflux in people with severe obesity. Fifty patients were randomly assigned to either the standard surgery or the enhanced version. After one year, the group with the extra steps reported fewer reflux symptoms. The findings suggest a simple surgical addition could improve quality of life after weight-loss surgery.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Laparoscopic sleeve gastrectomy with crural repair and gastropexy
What this could lead to
If successful, this surgical technique could reduce acid reflux after weight-loss surgery, improving patient comfort and reducing medication use.
What could go wrong
This is a small, single-center study with only 50 participants. Results may not apply to all patients, and the added procedure could increase surgical time or risks.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

50 people

The number who actually took part.

Started

Nov 2022

Finished

Jul 2024

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age between 18 and 65 years * Diagnosis of severe obesity for at least five years, defined as body mass index (BMI) \> 40 kg/m², or BMI \> 35 kg/m² in the presence of obesity-related comorbidities * Temporary or inadequate weight-loss response to a dietitian-supervised medical weight-management programme * Absence of hiatal hernia on preoperative upper gastrointestinal endoscopy * Willingness to participate and ability to provide written informed consent Exclusion Criteria: * Refusal to provide informed consent * History of upper gastrointestinal surgery * Presence of gastric ulcer, esophagitis, or hiatal hernia on preoperative upper gastrointestinal endoscopy * Known allergy to any of the planned postoperative medications (proton pump inhibitors, H2-receptor antagonists, paracetamol, or tramadol) * Known coagulopathy * Peripheral vascular disease * History of cerebrovascular accident * Intraoperative conversion to a bariatric procedure other than laparoscopic sleeve gastrectomy (LSG)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Gastroesophageal reflux disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

gastroesophageal reflux disease morbid obesity

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Gastroesophageal reflux disease Obesity, morbid

Contacts and locations

Locations

  • Van Training and Research Hospital

    Van, Van, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.